MD

Mundrika Devi

Active Director Director DIN 10246348
DIN 10246348 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Mundrika Devi

Data last updated:

Mundrika Devi is a Director at Hanmax Health Care Private Limited (since 2023). Hanmax Health Care Private Limited reported revenue of ₹2.1 Lakh (FY 2025).

DIN 10246348
Primary Designation Director
First Appointment 20 Jul 2023
Oldest Company Age 3 yrs
Largest company Hanmax Health Care Private Limited · ₹2.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hanmax Health Care Private Limited U86909BR2023PTC064193
Director20 Jul 20232023₹2.1 Lakh (FY 2025)Active

Board colleagues of Mundrika Devi

NameDINCompanyDesignation
Rajeev Ranjan Mishra10246349Hanmax Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hanmax Health Care Private Limited
Premium access

Shareholding and investment profile for Mundrika Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mundrika Devi

Mundrika Devi currently holds 1 directorship: Hanmax Health Care Private Limited (Director, since 20 Jul 2023, revenue ₹2.1 Lakh (FY 2025)).

Mundrika Devi was first appointed on 20 Jul 2023 as Director at Hanmax Health Care Private Limited.

The current boards of Mundrika Devi's companies include Rajeev Ranjan Mishra (Hanmax Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available